Price Alert

Maze Therapeutics Inc. (MAZE)

NASDAQ: MAZE · Real-Time Price · USD

13.49

0.14 (1.05%)

At close: Aug 15, 2025, 3:59 PM

13.50

0.07%

After-hours: Aug 15, 2025, 05:38 PM EDT

Maze Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Net Income	-120.8M	51.94M	52.23M	55.23M	55.24M	-83.82M	-51.32M	-24.75M
Depreciation & Amortization	2.83M	3.03M	3.3M	3.57M	3.78M	2.93M	1.98M	1M
Stock-Based Compensation	11.66M	10.56M	9.65M	9.35M	9.12M	6.98M	4.67M	2.11M
Other Working Capital	-8.16M	-3.81M	-1.32M	-3.75M	517K	-1.52M	-2.02M	206K
Other Non-Cash Items	7.75M	7.54M	12.3M	14.41M	11.46M	10.89M	5.34M	695K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-6.66M	-3.2M	-1.52M	-4.8M	1.39M	-1.04M	-1.28M	963K
Operating Cash Flow	-105.22M	69.88M	75.95M	77.76M	81M	-64.05M	-40.62M	-19.97M
Capital Expenditures	-1.4M	-1.17M	-1.15M	-576K	-470K	-310K	-31K	3K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-1.4M	-1.17M	-1.15M	-576K	-470K	-310K	-31K	3K
Debt Repayment	-16.18M	-15.92M	8.3M	40.65M	40.65M	40.39M	16.18M	n/a
Common Stock Repurchased	612K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	13.65M	13.55M	13.92M	-2.25M	-97K	8K	8K	8K
Financial Cash Flow	196.1M	195.64M	92.85M	38.77M	40.93M	40.78M	16.2M	8K
Net Cash Flow	89.48M	264.35M	167.65M	115.96M	121.46M	-23.59M	-24.45M	-19.96M
Free Cash Flow	-106.63M	68.71M	74.81M	77.19M	80.53M	-64.36M	-40.65M	-19.97M